Sam Scientist from Springfield was hired by Big Pharma Inc. to research new drugs. On his first day, Sam, who was the company’s first African-American employee, was given an employee handbook that said that employees would be treated fairly, that he would only be fired for good cause and that Sam was here to work so no unproductive doodling was allowed on the job. While doodling one morning while on a corporate jet on its way to a conference in Boston, Sam invented an ink that would make someone forget anything they had read printed in that ink after two weeks.
Sam’s manager punished him for doodling by putting a memo in his file that Sam now had one strike. Big Pharma Inc. filed a patent for the ink invented by Sam. Sam was not given any of the profits from his ink, even though other scientists, all of whom were white, were given bonuses for inventing new drugs.
Big Pharma Inc. started a subsidiary, Fair Use LLC, to publish books using Sam’s ink. Fair Use LLC was owned 50% by Big Pharma Inc. and 50% by Big Pharma’s CEO and his secretary/mistress. Fair Use’s business model was simply to republish all best sellers without paying royalties to the authors. When Sam complained that he should be given 25% of Fair Use LLC, he was fired.